Faculty, Staff and Student Publications
Publication Date
8-1-2022
Journal
Radiology Case Reports
Abstract
On December 2020, the US Food and Drug Administration issued the first emergency use authorization for a vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We report development of superficial thrombophlebitis in the ipsilateral breast of a 43-year-old female 7 days after receiving the first dose of the Pfizer-BioNTech COVID-19 vaccine. Given that this is the first case of superficial thrombophlebitis in the breast shortly after mRNA vaccination for COVID-19 reported to our knowledge, we suggest that this may be a rare vaccine-related event.
Keywords
COVID, COVID19 vaccine, Mondor’s disease, mRNA vaccination, superficial thrombophlebitis.
DOI
10.1016/j.radcr.2022.05.018
PMID
35711742
PMCID
PMC9189435
PubMedCentral® Posted Date
June 2022
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes
Included in
Clinical Epidemiology Commons, COVID-19 Commons, Hematology Commons, Hemic and Lymphatic Diseases Commons, Influenza Humans Commons, Influenza Virus Vaccines Commons, Radiology Commons